Skip to content
10-Q

Quarterly Report

BIOPLUS LIFE CORP

0001493152-20-019985

← back to feed
Filed
Oct 27, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Oct 12, 2020 362.91M sh
Current Liabilities Q1 2020 · Mar 31, 2020 $714.63K
Current Liabilities Q1 2020 · Dec 31, 2019 $782.81K
Total Liabilities Q1 2020 · Mar 31, 2020 $1.37M
Total Liabilities Q1 2020 · Dec 31, 2019 $1.47M
Current Assets Q1 2020 · Mar 31, 2020 $940.63K
Current Assets Q1 2020 · Dec 31, 2019 $989.71K
Operating Income Q1 2020 · Mar 31, 2020 $8.22K
Operating Income Q1 2020 · Mar 31, 2019 −$52.4K
Cash And Equivalents Q1 2020 · Dec 31, 2019 $210.74K
Total Assets Q1 2020 · Dec 31, 2019 $3.21M
Capex Q1 2020 · Mar 31, 2019 $7.36K
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$110.7K
Sga Expense Q1 2020 · Mar 31, 2019 $201.41K
Net Income Q1 2020 · Mar 31, 2019 −$24.41K
Gross Profit Q1 2020 · Mar 31, 2019 $156K
Cost Of Revenue Q1 2020 · Mar 31, 2019 $201.94K
Revenue Q1 2020 · Mar 31, 2019 $357.94K